Published in J Med Primatol on January 01, 1982
Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol (1989) 4.69
A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA (1992) 3.96
Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U S A (1995) 3.51
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest (2001) 3.24
Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation (1997) 3.23
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol (1994) 3.22
Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell (1991) 3.19
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation (1998) 2.88
Developmental changes due to long-distance movement of a homeobox fusion transcript in tomato. Science (2001) 2.75
DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera. J Clin Invest (1973) 2.66
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol (1998) 2.57
Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest (1998) 2.41
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment. J Clin Oncol (2000) 2.38
Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart (2007) 2.30
Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest (1996) 2.30
Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet (2000) 2.24
A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. Am J Pathol (1976) 2.23
Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation (1996) 2.06
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation. Int J Radiat Oncol Biol Phys (1995) 2.05
Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr (1992) 2.03
Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem (1993) 2.01
An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr (1982) 1.99
Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG. J Immunol (1982) 1.96
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood (1988) 1.95
Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol (1992) 1.94
Long-term culture of normal mouse B lymphocytes. Proc Natl Acad Sci U S A (1981) 1.94
A contagious pox disease in monkeys. J Am Vet Med Assoc (1967) 1.90
Interstitial nephritis due to methicillin, penicillin and ampicillin. Ann Allergy (1970) 1.88
Bronchiectasis: update of an orphan disease. Am Rev Respir Dis (1988) 1.79
Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet (1987) 1.77
Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med (1995) 1.77
A pox disease in monkeys transmitted to man. Clinical and histological features. Arch Dermatol (1968) 1.75
Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone (2002) 1.72
Comparative nephrotoxicity of gentamicin and tobramycin in rats. Antimicrob Agents Chemother (1978) 1.69
Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin Exp Immunol (1973) 1.68
Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections. Eur J Clin Microbiol (1985) 1.59
Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke (1999) 1.59
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis (1989) 1.57
Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis (1982) 1.55
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood (1998) 1.54
[Vertebral manifestation of chronic recurrent multifocal osteomyelitis (CRMO)]. Rofo (2002) 1.51
The diagnosis and treatment of Raynaud's phenomenon. Surgery (1975) 1.51
Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res (2001) 1.50
The plasma lipids, lipoproteins, and diet of the Tarahumara indians of Mexico. Am J Clin Nutr (1978) 1.49
The clinical spectrum of aspergillosis--part 2: classification and description of saprophytic, allergic, and invasive variants of human disease. Crit Rev Clin Lab Sci (1981) 1.46
Reaming versus non-reaming in medullary nailing: interference with cortical circulation of the canine tibia. Arch Orthop Trauma Surg (1990) 1.42
A case-control study assessing bone mineral density in severe haemophilia A in the UK. Haemophilia (2014) 1.41
Shared antigens between Mycobacterium bovis (BCG) and other bacterial species. Science (1972) 1.41
Genetic associates/counselors in genetics services. Am J Med Genet (1980) 1.39
Regression of atherosclerosis in humans: fact or myth? Circulation (1981) 1.38
The three "Rs": reform, rationing and their repercussions on the allergist/immunologist in the United States. Ann Allergy (1993) 1.38
Benign giant cell tumor of bone with osteosarcomatous transformation ("dedifferentiated" primary malignant GCT): report of two cases. Skeletal Radiol (1997) 1.36
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. J Infect Dis (1988) 1.36
Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. N Engl J Med (1979) 1.35
In vitro characteristics of a poxvirus isolated from rhesus monkeys. Nature (1968) 1.33
Role of the thymus in directing the development of a subset of B lymphocytes. J Exp Med (1982) 1.32
Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol (2000) 1.30
The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE). Am J Med (1975) 1.30
The fibroma-like variant of epithelioid sarcoma. A fibrohistiocytic/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer (1992) 1.27
Neurological disease associated with antiphospholipid antibodies. Ann Neurol (1989) 1.26
The clinical significance of Raynaud's syndrome. Surgery (1976) 1.25
The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood (1981) 1.24
Vancomycin enhancement of experimental tobramycin nephrotoxicity. Antimicrob Agents Chemother (1986) 1.24
Prevalence of generalised osteoarthritis in patients with advanced hip and knee osteoarthritis: the Ulm Osteoarthritis Study. Ann Rheum Dis (1998) 1.22
Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design. Neuroepidemiology (2001) 1.21
Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke (1990) 1.21
Richter's syndrome: a report on 39 patients. J Clin Oncol (1993) 1.19
Relationship between static and dynamic balance tests among elite Australian Footballers. J Sci Med Sport (2006) 1.19
Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol (1990) 1.19
Pulmonary hypersensitivity to Alternaria and Aspergillus in baker's asthma. Clin Allergy (1977) 1.18
Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am J Physiol Heart Circ Physiol (2000) 1.18
Defibrination after brain-tissue destruction: A serious complication of head injury. N Engl J Med (1974) 1.17
Predictive testing for Huntington disease: a psychologist's view. Am J Med Genet (1994) 1.15
Digital ischemia and gangrene preceding renal neoplasm. An association with sarcomatoid adenocarcinoma of the kidney. Arch Intern Med (1976) 1.14
The general and specific humoral immune response to pulmonary aspergillosis. Am Rev Respir Dis (1975) 1.14
A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels. J Clin Oncol (1989) 1.13
Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis (2001) 1.11
Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol (1978) 1.10
Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. Ann Intern Med (1974) 1.10
[Chronic recurrent multifocal osteomyelitis-- I. Review]. Klin Padiatr (2001) 1.10
Long-term results with radiotherapy for Stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys (2001) 1.09
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med (1998) 1.09
Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy. J Clin Oncol (1984) 1.09
Chronic intravascular coagulation in Kasabach-Merritt syndrome. Preferential accumulation of fibrinogen 131 I in a giant hemangioma. Arch Intern Med (1972) 1.09
Clinical spectrum of cryptogenic organising pneumonitis. Thorax (1991) 1.08
Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother (1985) 1.08
Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas. J Clin Oncol (1993) 1.07
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP. J Clin Oncol (1995) 1.07
Antiphospholipid antibodies, prethrombotic states, and stroke. Stroke (1990) 1.07
Radionuclide angiographic evaluation of ventricular function in isolated congenitally corrected transposition of the great arteries. Am J Cardiol (1986) 1.07
Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease. Int J Radiat Oncol Biol Phys (1992) 1.06
Toxicity and fetotoxicity of TCDD, TCDF and PCB isomers in rhesus macaques (Macaca mulatta). Environ Health Perspect (1985) 1.06
A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke (1994) 1.06
Heterogeneity of Ia expression on normal B cells, neonatal B cells, and on cells from B cell-defective CBA/N mice. J Immunol (1980) 1.06
Unusual and fatal complications of rhinoplasty. Arch Otolaryngol (1983) 1.06
Multiple peripheral lung cysts and hemoptysis in an otherwise asymptomatic adult. Am Rev Respir Dis (1982) 1.06
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma. Ann Oncol (2003) 1.05
The clinical spectrum of aspergillosis--part 1: epidemiology, pathogenicity, infection in animals and immunology of Aspergillus. Crit Rev Clin Lab Sci (1981) 1.05